Related Experiment Video
Updated: Dec 9, 2025

Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery
Published on: June 28, 2019
The Effect of Cell Surface Expression and Linker Sequence on the Recruitment of Arrestin to the GIP Receptor
Suleiman Al-Sabah1, Lobna Adi1, Moritz Bünemann2
1Department of Pharmacology and Toxicology, Faculty of Medicine, Kuwait University, Kuwait City, Kuwait.
Abstract:
The glucose-dependent insulinotropic polypeptide (GIP) and the glucagon-like peptide-1 (GLP-1) receptor are important targets in the treatment of both type 2 diabetes mellitus (T2DM) and obesity. Originally identified for their role in desensitization, internalization and recycling of G protein-coupled receptors (GPCRs), arrestins have since been shown to act as scaffolding proteins that allow GPCRs to signal in a G protein-independent manner. While GLP-1R has been reported to interact with arrestins, this aspect of cell signaling remains controversial for GIPR. Using a (FRET)-based assay we have previously shown that yellow fluorescent protein (YFP)-labeled GIPR does not recruit arrestin. This GIPR-YFP construct contained a 10 amino acid linker between the receptor and a XbaI restriction site upstream of the YFP. This linker was not present in the modified GIPR-SYFP2 used in subsequent FRET and bioluminescence resonance energy transfer (BRET) assays. However, its removal results in the introduction of a serine residue adjacent to the end of GIPR's C-terminal tail which could potentially be a phosphorylation site. The resulting receptor was indeed able to recruit arrestin. To find out whether the serine/arginine (SR) coded by the XbaI site was indeed the source of the problem, it was substituted with glycine/glycine (GG) by site-directed mutagenesis. This substitution abolished arrestin recruitment in the BRET assay but only significantly reduced it in the FRET assay. In addition, we show that the presence of a N-terminal FLAG epitope and influenza hemagglutinin signal peptide were also required to detect arrestin recruitment to the GIPR, most likely by increasing receptor cell surface expression. These results demonstrate how arrestin recruitment assay configuration can dramatically alter the result. This becomes relevant when drug discovery programs aim to identify ligands with "biased agonist" properties.
Insights
Arrestin recruitment to the glucose-dependent insulinotropic polypeptide receptor (GIPR) is sensitive to assay configuration. Modifications like linker removal and specific amino acid substitutions significantly alter GIPR-arrestin interactions, impacting drug discovery for obesity and type 2 diabetes.
Area of Science:
- Pharmacology and Molecular Biology
- G protein-coupled receptor (GPCR) signaling
- Diabetes and Obesity Therapeutics
Background:
- Glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors are key targets for treating type 2 diabetes mellitus (T2DM) and obesity.
- Arrestins, initially known for receptor desensitization, also mediate G protein-independent signaling pathways.
- While GLP-1 receptor (GLP-1R) arrestin interaction is established, GIP receptor (GIPR) interaction remains debated.
Purpose of the Study:
- To investigate the controversial arrestin recruitment to the GIP receptor.
- To determine the impact of assay configuration, including receptor modifications and epitope tags, on GIPR-arrestin interactions.
- To understand how these findings influence the discovery of biased agonists for GIPR.
Main Methods:
- Utilized Förster Resonance Energy Transfer (FRET) and Bioluminescence Resonance Energy Transfer (BRET) assays to measure arrestin recruitment.
- Employed site-directed mutagenesis to substitute specific amino acids (SR to GG) at the GIPR C-terminus.
- Assessed the role of N-terminal FLAG epitope and influenza hemagglutinin signal peptide in GIPR cell surface expression and arrestin recruitment.
Main Results:
- A modified GIPR construct (GIPR-SYFP2) lacking a 10 amino acid linker showed arrestin recruitment, unlike the original GIPR-YFP construct.
- Substitution of the serine/arginine (SR) motif with glycine/glycine (GG) abolished arrestin recruitment in BRET assays and significantly reduced it in FRET assays.
- N-terminal FLAG and HA signal peptide tags were necessary for detectable arrestin recruitment, likely by enhancing receptor expression.
Conclusions:
- Assay configuration, including receptor linker sequences, specific amino acid residues, and epitope tags, critically influences the detection of GIPR-arrestin interactions.
- These findings highlight the complexity of studying arrestin recruitment to GIPR and the potential for artifactual results.
- Careful consideration of assay design is crucial for drug discovery programs seeking biased agonists targeting GPCRs like GIPR.
More Related Videos
Related Concept Videos
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Intracellular Signaling Affects Focal Adhesions
Some...
IP3/DAG Signaling Pathway
GPCR Desensitization
Amplifying Signals via Enzymatic Cascade
GPI Anchoring of Proteins in the ER Membrane
GPI-anchor structure
A sequence of 11 enzymatic reactions results in the synthesis of the complete GPI anchor consisting of a hydrophobic and a hydrophilic portion. The hydrophobic portion comprises phosphatidylinositol, while the hydrophilic part comprises polar groups like phosphoethanolamine,...

